Can mean central corneal thickness and its 24-hour fluctuation influence fluctuation of intraocular pressure?

Journal of Glaucoma

Volumn 19, Issue 6, 2010, Pages 418-423

  Fogagnolo, Paolo ^a   Capizzi, Federica ^b   Orzalesi, Nicola ^b   Figus, Michele ^c   Ferreras, Antonio ^d   Rossetti, Luca ^b  

^a Istituto di Ricovero e Cura A Carattere Scientifico   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF PISA   (Italy)

^d HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

24 hour; central corneal thickness; fluctuation; glaucoma; intraocular pressure

Indexed keywords

LATANOPROST; TIMOLOL; ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; BODY POSITION; CENTRAL CORNEAL THICKNESS; CLINICAL ARTICLE; CLINICAL EVALUATION; CORNEA THICKNESS; CORRELATION ANALYSIS; FEMALE; HUMAN; INTRAOCULAR PRESSURE; MALE; OPEN ANGLE GLAUCOMA; OUTCOME ASSESSMENT; PACHOMETRY; PRIORITY JOURNAL; REGRESSION ANALYSIS; SITTING; STUDENT T TEST; SUPINE POSITION; TONOMETER; BODY POSTURE; CIRCADIAN RHYTHM; CORNEA; GLAUCOMA, OPEN-ANGLE; MIDDLE AGED; OCULOPLETHYSMOGRAPHY; PATHOPHYSIOLOGY; PHYSIOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; CIRCADIAN RHYTHM; CORNEA; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; POSTURE; TONOMETRY, OCULAR;

EID: 77956025039     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/IJG.0b013e3181aff432     Document Type: Article

References (33)

1. AGIS Investigators. Advanced Glaucoma Intervention Study (AGIS), 7: the relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;130:429-440.
2. Higginbotham EJ, Gordon MO, Beiser JA, et al, Ocular Hypertension Treatment Study Group. The Ocular Hypertension Treatment Study: topical medication delays or prevents primary open-angle glaucoma in African American individuals. Arch Ophthalmol. 2004;122:813-820.
3. Leske MC, Heijl A, Hussein M, et al, Early Manifest Glaucoma Trial Group. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003;121:48-56.
4. Lichter PR, Musch DC, Gillespie BW, et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108:1943-1953.
5. Asrani S, Zeimer R, Wilensky J, et al. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma. 2000;9:134-142.
6. Bengtsson B, Leske MC, Hyman L, et al. Fluctuation of intraocular pressure and glaucoma progression in the Early Manifest Glaucoma Trial. Ophthalmology. 2007;114: 205-209.
7. Caprioli J, Coleman AL. Intraocular pressure fluctuation. A risk factor for visual field progression at low intraocular pressures in the Advanced Glaucoma Intervention Study. Ophthalmology. 2008;115:1123-1129.
8. Medeiros FA, Weinreb RN, Zangwill LM, et al. Long-term intraocular pressure fluctuations and risk of conversion from ocular hypertension to glaucoma. Ophthalmology. 2008;115: 934-940.
9. Blondeau P, Tétrault JP, Papamarkakis C. Diurnal variation of episcleral venous pressure in healthy patients: a pilot study. J Glaucoma. 2001;10:18-24.
10. Meyer JH, Brandi-Dohrn J, Funk J. Twenty four hour blood pressure monitoring in normal tension glaucoma. Br J Ophthalmol. 1996;80:864-867.
11. Orzalesi N, Rossetti L, Invernizzi T, et al. Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension. Invest Ophthalmol Vis Sci. 2000;41: 2566-2573.
12. Weinreb RN. Nocturnal rhythms of intraocular pressure. Arch Ophthalmol. 2006;124:269-270.
13. Fogagnolo P, Orzalesi N, Ferreras A, et al. The circadian curve of intraocular pressure. Can we estimate its characteristics during office hours? Invest Ophthalmol Vis Sci. 2009;50: 2209-2215.
14. Barkana Y, Anis S, Liebmann J, et al. Clinical utility of intraocular pressure monitoring outside of normal office hours in patients with glaucoma. Arch Ophthalmol. 2006;124: 793-797.
15. Doughty MJ, Zaman ML. Human corneal thickness and its impact on intraocular pressure measures: a review and metaanalysis approach. Surv Ophthalmol. 2000;44:367-408.
16. Dueker DK, Singh K, Lin SC, et al. Corneal thickness measurement in the management of primary open-angle glaucoma: a report by the American Academy of Ophthalmology. Ophthalmology. 2007;114:1779-1787.
17. Wickham L, Edmunds B, Murdoch IE. Central corneal thickness: will one measurement suffice? Ophthalmology. 2005; 112:225-228.
18. Nielsen CB, Nielsen PJ. Effect of alpha and beta-receptor active drugs on corneal thickness. Acta Ophthalmol. 1985;63: 351-354.
19. Lass JH, Eriksson GL, Osterling L, et al, Latanoprost Corneal Effects Study Group. Comparison of the corneal effects of latanoprost, fixed combination latanoprost-timolol, and timolol: a double-masked, randomized, one-year study. Ophthalmology. 2001;108:264-271.
20. Herman DC, Hodge DO, Bourne WM. Changes in corneal thickness in patients with treated and untreated ocular hypertension. Cornea. 2006;25:639-643.
21. Fogagnolo P, Rossetti L, Mazzolani F, et al. Circadian variations in central corneal thickness and intraocular pressure in patients with glaucoma. Br J Ophthalmol. 2006;90:24-28.
22. Harper CL, Boulton ME, Bennett D, et al. Diurnal variations in human corneal thickness. Br J Ophthalmol. 1996;80: 1068-1072.
23. Kida T, Liu JHK, Weinreb RN. Effect of 24-hour corneal biomechanical changes on intraocular pressure measurement. Invest Ophthalmol Vis Sci. 2006;47:4422-4426.
24. Kida T, Liu JH, Weinreb RN. Effects of aging on corneal biomechanical properties and their impact on 24-hour measurement of intraocular pressure. Am J Ophthalmol. 2008; 146:567-572.
25. Tuulonen A, Airaksinen PJ. Initial glaucomatous optic disk and retinal nerve fiber layer abnormalities and their progression. Am J Ophthalmol. 1991;111:485-490.
26. Miglior S, Rossetti L, Brigatti L, et al. Reproducibility of retinal nerve fiber layer evaluation by dynamic scanning laser ophthalmoscopy. Am J Ophthalmol. 1994;118:16-23.
27. Liu JHK, Kripke DF, Hoffman RE, et al. Nocturnal elevation of intraocular pressure in young adults. Invest Ophthalmol Vis Sci. 1998;39:2707-2712.
28. Mosaed S, Chamberlain WD, Liu JH, et al. Association of central corneal thickness and 24-hour intraocular pressure fluctuation. J Glaucoma. 2008;17:85-88.
29. Aronowicz JD, Lieu P, Lubahn J, et al. American Glaucoma Society, 18th Annual Meeting, Washington DC, 2008:3.
30. Neufeld A, Bartels SP. Receptor mechanisms for epinephrine and timolol. In: Lütjen-Drecoll E, ed. Basic Aspects of Glaucoma Research. Stuttgart, Germany: Shattauer; 1982:113-122.
31. Abrams LS, Vitale S, Jampel HD. Comparison of three tonometers for measuring intraocular pressure in rabbits. Invest Ophthalmol Vis Sci. 1996;37:940-944.
32. Herndon LW, Choudhri SA, Cox T, et al. Central corneal thickness in normal, glaucomatous, and ocular hypertensive eyes. Arch Ophthalmol. 1997;115:1137-1141.
33. Damji KF, Muni RH, Munger RM. Influence of corneal variables on accuracy of intraocular pressure measurement. J Glaucoma. 2003;12:69-80.